Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2024-04-28 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
监事会对《董事会关于2023年度保留意见审计报告涉及事项的专项说明》的意见
Audit Report / Information Classification · 95% confidence The document is a formal announcement from the Supervisory Board regarding the company's 2023 audit report which contains a qualified opinion (保留意见审计报告). It discusses the auditor's inability to obtain sufficient evidence due to issues with the former controlling shareholder and the related financial risks. The Supervisory Board expresses its opinion on the Board of Directors' special explanation about the audit report. The document is short (669 characters) and focuses on the audit report and the Supervisory Board's opinion rather than presenting the full audit report or detailed financial statements. It is not the full Annual Report (10-K) or the audit report itself but an announcement related to the audit findings and the Supervisory Board's stance. Therefore, it fits best under Audit Report / Information (AR). FY 2023
2024-04-28 Chinese
国新证券股份有限公司关于云南生物谷药业股份有限公司的风险提示性公告
Regulatory Filings Classification · 95% confidence The document is a risk warning announcement issued by a securities company regarding a listed company, focusing on governance and financial risks, specifically mentioning a qualified audit opinion (保留意见) on the 2023 financial statements. It references an audit report and a special explanation related to the non-standard audit opinion. The document is relatively short (2126 characters) and primarily serves as a disclosure and risk alert rather than the full audit report itself. It does not contain the full financial statements or detailed audit findings but summarizes the risk issues and the audit opinion status. Therefore, it is not the audit report itself but an announcement related to audit findings and risk disclosures. Given the nature and content, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2024-04-28 Chinese
独立董事关于2023年度保留意见审计报告涉及事项的专项说明的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent directors' special statement regarding a 2023 audit report with a qualified opinion (保留意见审计报告). It discusses the audit issues related to the company's financial statements for the year 2023, specifically mentioning the auditor's inability to obtain sufficient evidence and the resulting qualified audit opinion. The document is not the full audit report itself but a statement by independent directors commenting on the audit report and its implications. The length is short (777 characters), and it does not contain full financial statements or detailed audit results, but rather an opinion and explanation related to the audit report. Therefore, it fits best under 'Audit Report / Information (AR)' as it relates to audit opinions and explanations about the audit findings, rather than a full annual report or a regulatory filing or announcement about the report. FY 2023
2024-04-28 Chinese
董事会关于2023年度保留意见审计报告涉及事项的专项说明
Audit Report / Information Classification · 95% confidence The document is a detailed announcement from the board of directors regarding a 2023 audit report with a qualified (reserved) opinion issued by the company's auditor. It explains the reasons for the qualified opinion, the basis under auditing standards, and the company's response and planned measures. The document focuses on the audit report's issues rather than presenting the full audit report or the full annual financial statements. It is not the full Annual Report (10-K) or the Audit Report (AR) itself but a board explanation related to the audit report's qualified opinion. Given the detailed explanation by the board about the audit report and related matters, this fits best under Audit Report / Information (AR), which covers standalone audit reports and related explanations excluding full annual reports. The document length is under 5,000 characters, but it contains substantive explanation rather than just a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the classification is AR with high confidence. FY 2023
2024-04-28 Chinese
2023年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" for the year 2023. It contains detailed financial data including assets, liabilities, net profit, earnings per share, and shareholder structure. It also discusses the company's business operations, shareholder changes, and legal matters related to shareholder disputes and fund occupation. The length of the document (10,983 characters) and the presence of comprehensive financial and operational data indicate this is the actual annual report or a substantial summary of it, not merely an announcement or a brief summary. The document includes audited financial figures and detailed disclosures typical of an Annual Report (10-K equivalent). Therefore, the appropriate classification is Annual Report (10-K). FY 2023
2024-04-28 Chinese
2023年审计报告
Regulatory Filings
2024-04-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.